Urinary tract infections in chronic kidney disease in Nephrology unit, University Hospital Center of Befelatanana, Antananarivo.

Journal

La Tunisie medicale
ISSN: 2724-7031
Titre abrégé: Tunis Med
Pays: Tunisia
ID NLM: 0413766

Informations de publication

Date de publication:
05 Aug 2024
Historique:
received: 03 02 2024
accepted: 30 05 2024
medline: 12 8 2024
pubmed: 12 8 2024
entrez: 12 8 2024
Statut: epublish

Résumé

Urinary tract infection is the leading cause of nosocomial infection worldwide. It is a factor in the progression of chronic kidney disease. To determine the epidemiological, clinical, microbiological, therapeutic and evolving profile of patients with chronic kidney disease and urinary tract infection. This was a retrospective, descriptive study lasting 5 years, from January 2014 to december 2018 in chronic kidney disease with urinary tract infection. Fifty-one patients (7.15%) were retained with a mean age of 53.03 years and a sex ratio of 0.55. Chronic kidney disease was in end-stage in 45.1% (n=23). Cystitis was found in 49.02% (n=25) and gram-negative bacilli were found in 74.50% (n=38), predominantly Escherichia coli (54.90%). Third generation of cephalosporins and fluoroquinolones were frequently prescribed as probabilistic antibiotics. Resistance to beta-lactam antibiotics was 50% for Escherichia coli. Factors influencing severe infection were: advanced age, male gender, urinary lithiasis, multiple antibiotic resistance and non-enterobacterial germs. Urinary tract infection in chronic kidney disease were frequent and particularly severe.

Identifiants

pubmed: 39129574
pii: /article/view/4830
doi: 10.62438/tunismed.v102i8.4830
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

English Abstract Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

472-477

Auteurs

Mihary Dodo (M)

Department of Internal Medicine, Analakininina University Hospital, Toamasina, Madagascar.

Faniry Notahiantsoa Ratrimoharilala (FN)

Nephrology Intensive Care Unit, Joseph Raseta Andrianavalona University Hospital, Madagascar.

Benja Ramilitiana (B)

Nephrology unit, university hospital center of Joseph Raseta Befelatanana, Antananarivo, Madagascar.

Catherine Razafindrakoto (C)

Laboratory unit, university hospital center of Morafeno, Toamasina, Madagascar.

Nomenjanahary Andriniaina Rakotoarisoa (NA)

Nephrology unit, university hospital center of Joseph Raseta Befelatanana, Antananarivo, Madagascar.

Lova Narindra Randriamanantsoa (LN)

Nephrology Intensive Care Unit, Joseph Raseta Andrianavalona University Hospital, Madagascar.

Harilalaina Willy Franck Randriamarotia (HWF)

Nephrology unit, university hospital center of Joseph Raseta Befelatanana, Antananarivo, Madagascar.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH